Landscapes / Targets

4-1BB

23 drugs act on 4-1BB, in 45 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs23

DrugHow it worksCompanyStageNext dateDetails
—
Phase 3 24 Dec 2026Phase 2 trial completes
PD-L1/4-1BB bispecific antibody
Phase 3 30 Jul 2027Phase 3 trial completes
—
Roche · Public ROG.SW
Phase 1/2 28 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 Dec 2026Phase 1/2 trial completes
—
Phase 1/2 Aug 2027Phase 1 trial completes
—
Phase 1/2 31 Aug 2027Phase 1/2 trial completes
—
Phase 2 31 Oct 2027Phase 2 trial completes
—
Phase 1/2 2 Dec 2027Phase 1/2 trial completes
—
Phase 2 Sep 2028Phase 2 trial completes
—
Phase 1/2 31 Dec 2029Phase 1/2 trial completes
—
Regeneron · Public REGN
Phase 1/2 27 Oct 2030Phase 1/2 trial completes
—
BioNTech · Public BNTX
Phase 1/2 Dec 2030Phase 1/2 trial completes
—
Phase 2 —
—
Phase 1/2 —
—
Phase 1/2 —
—
Phase 1 Dec 2026Phase 1 trial completes
—
Hanmi · Public 128940.KS
Phase 1 Aug 2027Phase 1 trial completes
—
Phase 1 30 Oct 2027Phase 1 trial completes

See all 23 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

About this list

Checked
23 of 23 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow 4-1BB

Following is part of Solo: you see every change to 4-1BB the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in